Ratings and reviews of the Best Small SUVs priced under $50K on the Australian market... plus our category winner.

Ratings and reviews of the Best Small SUVs priced over $50K on the Australian market... plus our category winner.

Estimated payments are calculated by Cars.com and are for informational ... Actual terms vary by lender. The 2020 Audi A3 2.0T S line Premium price depends on several factors, including optional ...

Audi chief executive Gernot Döllner told us: “We won’t step out of these segments; we will end production of the A1 and Q2 ... Q4 e-tron’s powertrain line-up, the entry cars are likely ...

Estimated payments are calculated by Cars.com and are for informational purposes ... by a governmental agency in connection with the sale and financing of the vehicle. Other taxes may apply.

Hello AUDI lovers. In this video you will see the 2025 Audi A5 S Line that we shot at the Brussels ... suggest eliminating TSA with idea already used at SFO Meet the dire wolves brought back ...

Audi’s littlest and most affordable SUV, the Q2 ... petrol four making 140kW and 320 Nm; and the SQ2 has a 2.0-litre turbo-petrol as well, but it puts out a very impressive 221kW and 400Nm. The 35 ...

Buying a modern used car for under £10k is almost impossible ... If you’re unhappy with Auto Express or Carwow’s service, you may be able to contact the Financial Ombudsman (please see ...

Tariffs for foreign automakers: Sweeping tariffs shake the auto industry and its consumers Audi is directly in the firing line of Trump's tariffs, with its bestselling U.S. model, the Q5 ...

Prime Minister Keir Starmer has confirmed the Government will reinstate the 2030 ban on the sale of new petrol and diesel cars ... used and bought second-hand beyond the deadline. However, it’s ...

Audi’s Virtual Cockpit makes an appearance ... The latest Passat in petrol-only form reminds us ‘normal’ cars can and should be above average ...

The top line surpassed the Zacks Consensus Estimate by 3.1%. SLP’s organic revenue growth during the quarter was 5%. However, the broader biopharma industry continues to experience cost pressure ...